Finance

Beta
Lists
XENE:NASDAQ
Xenon Pharmaceuticals Inc
$56.24
+2.98%
(+1.62) 1D
Jun 24, 11:55:04 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XENE...
Open
$54.61
High
$56.55
Low
$54.61
Mkt. cap
5.44B
Avg. vol.
1.33M
Volume
430.82K
52-wk high
$63.95
52-wk low
$30.00
EPS
-$4.70
Beta
0.62
Shares outstanding
96.67M
No. of employees
364
Open
$54.61
High
$56.55
Low
$54.61
Mkt. cap
5.44B
Avg. vol.
1.33M
Volume
430.82K
52-wk high
$63.95
52-wk low
$30.00
EPS
-$4.70
Beta
0.62
Shares outstanding
96.67M
No. of employees
364
News stories
From sources across the web
About Xenon Pharmaceuticals Inc
CEO-
Employees364
Founded1996
HeadquartersVancouver, British Columbia, Canada
SectorBiotechnology
Websitexenon-pharma.com
Analyst Ratings
Based on 11 analysts giving stock ratings to XENE in the past 3 months
Strong Buy
Buy
11
Hold
0
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for XENE in the last 3 months.
Highest
Current $56.24
$86.00 (+52.93%)
Average
$75.77 (+34.74%)
Lowest
$63.00 (+12.03%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Maintained
$63.00
+12%
06/22/2026
Benjamin Burnett
Wells Fargo
Buy
Maintained
$69.00
+22.7%
06/01/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
$82.00
+45.8%
05/27/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$80.00
+42.3%
05/08/2026
Laura Chico
Wedbush
Buy
Maintained
$63.00
+12%
05/08/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$82.00
+45.8%
05/07/2026
Serge Belanger
Needham
Buy
Maintained
$78.00
+38.7%
05/08/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
$74.00
+31.6%
05/08/2026
Joseph Thome
TD Cowen
Buy
Maintained
-
-
05/07/2026
Myles Minter
William Blair
Buy
Reiterated
$80.65
+43.4%
05/08/2026
Paul Matteis
Stifel Nicolaus
Buy
Maintained
$86.00
+52.9%
05/08/2026
David Martin PhD
Bloom Burton
Buy
Maintained
$74.00
+31.6%
03/09/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$90.00
+60%
03/09/2026
Paul Choi
Goldman Sachs
Buy
Maintained
$75.00
+33.4%
03/10/2026
David Hoang
Deutsche Bank
Buy
Maintained
$90.00
+60%
03/10/2026
Andrew Tsai
Jefferies
Buy
Reiterated
$100.00
+77.8%
03/09/2026
Brian Skorney
Robert W. Baird
Buy
Maintained
$97.00
+72.5%
03/09/2026
Jason Gerberry
Bank of America Securities
Buy
Reiterated
$77.00
+36.9%
03/09/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$55.00
-2.2%
02/26/2026
Rudy Li
Wolfe Research
Buy
Initiated
$60.00
+6.7%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
74.98M
77.05M
87.70M
88.51M
Cost of revenue
74.98M
77.05M
87.70M
88.51M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19.24M
19.28M
22.07M
23.82M
Operating expense
19.24M
19.28M
22.07M
23.82M
Total operating expenses
94.23M
96.34M
109.77M
112.33M
Operating income
-94.23M
-96.34M
-109.77M
-112.33M
Other non operating income
-
-
-
-
EBT including unusual items
-85.33M
-90.22M
-104.72M
-104.87M
EBT excluding unusual items
-85.33M
-90.22M
-104.72M
-104.87M
Income tax expense
-626.00K
677.00K
538.00K
-2.57M
Effective tax rate
0.73%
-0.75%
-0.51%
2.45%
Other operating expenses
-
-
-
-
Net income
-84.71M
-90.90M
-105.26M
-102.30M
Net profit margin
-
-
-
-
Earnings per share
-1.07
-1.15
-1.31
-1.17
Interest and investment income
7.20M
6.21M
5.34M
6.91M
Interest expense
-
-
-
-
Net interest expenses
7.20M
6.21M
5.34M
6.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
-93.60M
-95.70M
-109.16M
-111.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer